Evidence map›Paper›PMID 39463828›Full record

ArticleACS central science2024

Gentle Rhodamines for Live-Cell Fluorescence Microscopy.

Tianyan Liu, Julian Kompa, Jing Ling, Nicolas Lardon, Yuan Zhang, Jingting Chen, Luc Reymond, Peng Chen, Mai Tran, Zhongtian Yang and 7 more

Abstract read
In one paragraph

Article in ACS central science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Thioether editing generally increases the photostability of rhodamine dyes on self-labeling tags.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. A gentle palette of plasma membrane dyes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tianyan LiuCollege of Future Technology, Institute of Molecular Medicine, National Biomedical Imaging Center, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing 100871, China.
Julian KompaDepartment of Chemical Biology, Max Planck Institute for Medical Research, Heidelberg 69120, Germany.ORCID https://orcid.org/0000-0002-4479-5429
Jing LingCollege of Future Technology, Institute of Molecular Medicine, National Biomedical Imaging Center, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing 100871, China.ORCID https://orcid.org/0000-0003-4620-9507
Nicolas LardonDepartment of Chemical Biology, Max Planck Institute for Medical Research, Heidelberg 69120, Germany.
Yuan ZhangCollege of Future Technology, Institute of Molecular Medicine, National Biomedical Imaging Center, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing 100871, China.
Jingting ChenCollege of Future Technology, Institute of Molecular Medicine, National Biomedical Imaging Center, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing 100871, China.
Luc ReymondBiomolecular Screening Facility, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne 1015, Switzerland.
Peng ChenPKU-Nanjing Institute of Translational Medicine, Nanjing 211800, China.
Mai TranDepartment of Chemical Biology, Max Planck Institute for Medical Research, Heidelberg 69120, Germany.ORCID https://orcid.org/0000-0003-1666-4584
Zhongtian YangCollege of Future Technology, Institute of Molecular Medicine, National Biomedical Imaging Center, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing 100871, China.
Haolin ZhangCollege of Future Technology, Institute of Molecular Medicine, National Biomedical Imaging Center, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing 100871, China.
Yitong LiuCollege of Future Technology, Institute of Molecular Medicine, National Biomedical Imaging Center, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing 100871, China.
Stefan PitschSpirochrome AG, Chalberwiedstrasse 4, CH-8260 Stein am Rhein, Switzerland.
Peng ZouPeking-Tsinghua Center for Life Science, Academy for Advanced Interdisciplinary Studies, State Key Laboratory of Membrane Biology, Peking University, Beijing 100871, China.ORCID https://orcid.org/0000-0002-9798-5242
Lu WangKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, 201203 Shanghai, China.ORCID https://orcid.org/0000-0001-8412-2985
Kai JohnssonDepartment of Chemical Biology, Max Planck Institute for Medical Research, Heidelberg 69120, Germany.
Zhixing ChenCollege of Future Technology, Institute of Molecular Medicine, National Biomedical Imaging Center, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing 100871, China.ORCID https://orcid.org/0000-0001-5962-7359

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhodamines have been continuously optimized in brightness, biocompatibility, and color to fulfill the demands of modern bioimaging. However, the problem of phototoxicity caused by the excited fluorophore under long-term illumination has been largely neglected, hampering their use in time-lapse imaging. Here we introduce cyclooctatetraene (COT) conjugated rhodamines that span the visible spectrum and exhibit significantly reduced phototoxicity. We identified a general strategy for the generation of Gentle Rhodamines, which preserved their outstanding spectroscopic properties and cell permeability while showing an efficient reduction of singlet-oxygen formation and diminished cellular photodamage. Paradoxically, their photobleaching kinetics do not go hand in hand with reduced phototoxicity. By combining COT-conjugated spirocyclization motifs with targeting moieties, these Gentle Rhodamines compose a toolkit for time-lapse imaging of mitochondria, DNA, and actin, and synergize with covalent and exchangeable HaloTag labeling of cellular proteins with less photodamage than their commonly used precursors. Taken together, the Gentle Rhodamines generally offer alleviated phototoxicity and allow advanced video recording applications, including voltage imaging.

Identifiers

PMID39463828
PMCPMC11503488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.